Evidence map›Paper›PMID 30558189›Full record

ReviewInternational journal of molecular sciences2018

Perspectives of RAS and RHEB GTPase Signaling Pathways in Regenerating Brain Neurons.

Hendrik Schöneborn, Fabian Raudzus, Mathieu Coppey, Sebastian Neumann, Rolf Heumann

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hendrik SchönebornRuhr-Universität Bochum, Faculty of Chemistry and Biochemistry, Department of Biochemistry II-Molecular Neurobiochemistry, 44801 Bochum, Germany. hendrik.schoeneborn@ruhr-uni-bochum.de.ORCID 0000-0002-8913-2987
Fabian RaudzusRuhr-Universität Bochum, Faculty of Chemistry and Biochemistry, Department of Biochemistry II-Molecular Neurobiochemistry, 44801 Bochum, Germany. fabian.raudzus@ruhr-uni-bochum.de.ORCID 0000-0001-8327-2076
Mathieu CoppeyLaboratoire Physico-Chimie, Institut Curie, CNRS UMR168, PSL Research University, Universite Pierre et Marie Curie-Paris, 75005 Paris, France. mathieu.coppey@curie.fr.ORCID 0000-0001-8924-3233
Sebastian NeumannRuhr-Universität Bochum, Faculty of Chemistry and Biochemistry, Department of Biochemistry II-Molecular Neurobiochemistry, 44801 Bochum, Germany. sebastian.neumann@ruhr-uni-bochum.de.ORCID 0000-0003-3706-9012
Rolf HeumannRuhr-Universität Bochum, Faculty of Chemistry and Biochemistry, Department of Biochemistry II-Molecular Neurobiochemistry, 44801 Bochum, Germany. rolf.heumann@ruhr-uni-bochum.de.ORCID 0000-0003-4364-2655
Ruhr University Bochum · DECentre National de la Recherche Scientifique · FR

Funding

H2020 Future and Emerging Technologies 686841
6 · The paper itself

Abstract

Cellular activation of RAS GTPases into the GTP-binding "ON" state is a key switch for regulating brain functions. Molecular protein structural elements of rat sarcoma (RAS) and RAS homolog protein enriched in brain (RHEB) GTPases involved in this switch are discussed including their subcellular membrane localization for triggering specific signaling pathways resulting in regulation of synaptic connectivity, axonal growth, differentiation, migration, cytoskeletal dynamics, neural protection, and apoptosis. A beneficial role of neuronal H-RAS activity is suggested from cellular and animal models of neurodegenerative diseases. Recent experiments on optogenetic regulation offer insights into the spatiotemporal aspects controlling RAS/mitogen activated protein kinase (MAPK) or phosphoinositide-3 kinase (PI3K) pathways. As optogenetic manipulation of cellular signaling in deep brain regions critically requires penetration of light through large distances of absorbing tissue, we discuss magnetic guidance of re-growing axons as a complementary approach. In Parkinson's disease, dopaminergic neuronal cell bodies degenerate in the substantia nigra. Current human trials of stem cell-derived dopaminergic neurons must take into account the inability of neuronal axons navigating over a large distance from the grafted site into striatal target regions. Grafting dopaminergic precursor neurons directly into the degenerating substantia nigra is discussed as a novel concept aiming to guide axonal growth by activating GTPase signaling through protein-functionalized intracellular magnetic nanoparticles responding to external magnets.

Indexed as

AnimalsBrainCell DifferentiationCell MovementHumansNeurogenesisOptogeneticsRas Homolog Enriched in Brain Proteinras ProteinsSignal TransductionRas Homolog Enriched in Brain Proteinras Proteinsaxonal guidancebrain regenerationmagnetogeneticsMagneto Protein TherapynanoparticleoptogeneticsParkinson’s diseaseRAS GTPaseRHEB GTPasesurvival

Identifiers

PMID30558189
PMCPMC6321366
OpenAlexW2904568655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.